Preparation and Evaluation of Sodium Alginate Microparticles using Pepsin
Aim: The main aim of this article is to prepare and evaluate sodium alginate microparticles and evaluate on the basis of their characterization. The drug is dissolved, encapsulated or attached to a microparticles matrix. Depending upon method of preparation microparticles were obtained. Microparticles were developed as a carrier for vaccines and other disease like rheumatoid arthritis, cancer etc. Microparticles were developed to increase the efficacy of active pharmaceutical ingredient to a specific targeted site.
Material and Method: Microparticles of Sodium Alginate, Pepsin and Calcium Chloride were prepared in six batches (A-F) with different ratio of sodium alginate and calcium chloride respectively i.e. (0.25:2.5), (0.25:5), (0.25:7.5), (0.5:2.5), (0.5:5), (0.5:7.5) by using a homogenizing method. Microparticles were evaluated for particle size distribution, zeta potential and morphology.
Result and Discussion: The normal particle size of each of the six batches were analyzed by Zeta Sizer (Delsa C Particle Analyzer) and it was found that the Batch B (0.25:5) delivered the best microparticles with size distribution of 1.2731 (µm). All batches were seen under Motic magnifying microscope by using the Sulforhodamine B (M.W. 479.02) color as staining dye. Microparticles was found to be semi spherical in shape.
Conclusion: Results of all the six batches was contrasted based on particle size investigation, zeta potential and morphology. Batch B (0.25:5) was considered as the best formulation.
Key words: Micro Particle, Pepsin, Sodium Alginate and Calcium Chloride, Sulforhodamine B, Zeta Sizer.
2. Garcia-Garcia E., et al., Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? International journal of pharmaceutics, 2005; 298(2):274-292.
3. Parveen S. and S.K. Sahoo, Polymeric nanoparticles for cancer therapy. Journal of drug targeting, 2008; 16(2):;108-123.
4. Klose D., et al., How porosity and size affect the drug release mechanisms from PLGA-based microparticles. International journal of pharmaceutics, 2006; 314(2):198-206.
5. Soppimath K.S., et al., Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release, 2001; 70(1-2):1-20.
6. Putnam D., Polymers for gene delivery across length scales. Nature materials, 2006; 5(6):439-451.
7. Ensign L.M., Cone R, and Hanes J, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Advanced drug delivery reviews, 2012; 64(6):557-570.
8. Santini J., John T, et al., Microchips as controlled drug‐delivery devices. Angewandte Chemie International Edition, 2000; 39(14):2396-2407.
9. Lloyd A.L., Cloning, characterisation and sequencing of promoters of Helicobacter pylori 4187E. 2004: University of Western Australia.
10. Andrianov A.K. and Payne LG, Polymeric carriers for oral uptake of microparticulates. Advanced drug delivery reviews, 1998; 34(2-3):155-170.
11. Patil P., Chavanke D, and Wagh M, A review on ionotropic gelation method: novel approach for controlled gastroretentive gelispheres. Int J Pharm Pharm Sci, 2012; 4(4):27-32.
12. Sun J. and Tan H, Alginate-based biomaterials for regenerative medicine applications. Materials, 2013; 6(4):1285-1309.
13. Kumar M.R., et al., Chitosan chemistry and pharmaceutical perspectives. Chemical reviews, 2004; 104(12):6017-6084.
14. Xu R., Progress in nanoparticles characterization: Sizing and zeta potential measurement. Particuology, 2008; 6(2):112-115.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).